Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

Emerging evidence supports a prognostic role of primary tumor location in metastatic colon cancer (mCC). We conducted a retrospective analysis to evaluate the effect of tumor location on prognosis and efficacy of biological agents (anti-EGFR, Cetuximab and Panitumumab, or anti-VEGF, Bevacizumab) add...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassadonia, Antonino, Di Marino, Pietro, Ficorella, Corrado, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Gamucci, Teresa, Zoratto, Federica, Vici, Patrizia, Barba, Maddalena, Porreca, Ettore, Neri, Matteo, Veronese, Angelo, Natoli, Clara, De Tursi, Michele, Tinari, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856567/
https://www.ncbi.nlm.nih.gov/pubmed/31762802
http://dx.doi.org/10.7150/jca.34550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856567/
https://www.ncbi.nlm.nih.gov/pubmed/31762802
http://dx.doi.org/10.7150/jca.34550

Ejemplares similares